Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Patent for p53/taxane combination therapy awarded to Aventis, licensed to Introgen

Dec. 11, 2002

Epimmune files IND for cancer vaccine

Dec. 10, 2002

Millennium to submit Velcade NDA and MAA filings by early 2003

Dec. 10, 2002

huN901-DM1 enters phase II portion of U.S. SCLC study

Dec. 10, 2002

Corixa and Kirin collaborate on WT1 cancer vaccine development

Dec. 9, 2002

Apoptosis-inducing hydrazones as novel antitumor agents

Dec. 9, 2002

Vertex researchers describe novel series of ERK inhibitors

Dec. 9, 2002

CeMines and CePeP enter pilot program for peptide-based cancer drugs

Dec. 9, 2002

No cytotoxic effect reported for seocalcitol monotherapy in pancreatic cancer

Dec. 9, 2002

High response rate found for temozolomide plus celecoxib in recurrent malignant glioma

Dec. 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...